These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 34337994)

  • 1. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
    Bloudek LM; Pandey R; Fazioli K; Ollendorf DA; Carlson JJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1046-1055. PubMed ID: 34337994
    [No Abstract]   [Full Text] [Related]  

  • 2. The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.
    Pandey R; Ollendorf DA; Fazioli K; Bloudek L; Carlson JJ; Pearson SD
    J Manag Care Spec Pharm; 2021 Mar; 27(3):405-410. PubMed ID: 33645245
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF; Rind DM; Fazioli K; Chapman RH; Pearson SD; Hansen RN
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma.
    Beinfeld M; Lee S; McQueen B; Fluetsch N; Pearson SD; Ollendorf DA
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1315-1320. PubMed ID: 34464215
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.
    Hendrix N; Ollendorf DA; Chapman RH; Loos A; Liu S; Kumar V; Linder JA; Pearson SD; Veenstra DL
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1210-1217. PubMed ID: 30479197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treatments for outpatient COVID-19: Effectiveness and value.
    Beinfeld M; Yeung K; Whittington MD; Mohammed R; Nhan E; Pearson SD
    J Manag Care Spec Pharm; 2022 Aug; 28(8):903-909. PubMed ID: 35876296
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.
    Tice JA; Walton SM; Sarker J; Moradi A; Chu JN; Herce-Hagiwara B; Fahim SM; Agboola F; Rind D; Pearson SD
    J Manag Care Spec Pharm; 2023 May; 29(5):576-581. PubMed ID: 37121251
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder.
    Tice JA; Whittington MD; Campbell JD; Pearson SD
    J Manag Care Spec Pharm; 2021 Apr; 27(4):528-532. PubMed ID: 33769860
    [No Abstract]   [Full Text] [Related]  

  • 9. The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease.
    Synnott PG; McQueen RB; Ollendorf DA; Campbell JD; Pearson SD
    J Manag Care Spec Pharm; 2020 Jun; 26(6):782-785. PubMed ID: 32463783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and value of belimumab and voclosporin for lupus nephritis.
    Tice JA; Mandrik O; Thokala P; Fotheringham J; Pearson SD
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1495-1499. PubMed ID: 34595943
    [No Abstract]   [Full Text] [Related]  

  • 11. The effectiveness and value of aducanumab for Alzheimer's disease.
    Synnott PG; Whittington MD; Lin GA; Rind DM; Pearson SD
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1613-1617. PubMed ID: 34714106
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis.
    Synnott PG; Bloudek LM; Sharaf R; Carlson JJ; Pearson SD
    J Manag Care Spec Pharm; 2020 Mar; 26(3):236-239. PubMed ID: 32105176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value.
    Beinfeld M; Wasfy JH; Walton S; Sarker J; Nhan E; Rind DM; Pearson SD
    J Manag Care Spec Pharm; 2022 Mar; 28(3):369-375. PubMed ID: 35199575
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors.
    Agboola F; Rind DM; Walton SM; Herron-Smith S; Quach D; Pearson SD
    J Manag Care Spec Pharm; 2021 May; 27(5):667-673. PubMed ID: 33908280
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapies for sickle cell disease: Effectiveness and value.
    Nikitin D; Beaudoin FL; Thokala P; McKenna A; Nhan E; Rind DM; Pearson SD
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1253-1259. PubMed ID: 37889869
    [No Abstract]   [Full Text] [Related]  

  • 16. The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancer.
    Beinfeld M; Atlas SJ; Touchette D; McKenna A; Rind D; Pearson SD
    J Manag Care Spec Pharm; 2021 Jun; 27(6):797-804. PubMed ID: 34057394
    [No Abstract]   [Full Text] [Related]  

  • 17. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value.
    Agboola F; Atlas SJ; Brouwer E; Carlson JJ; Hansen RN; Herron-Smith S; Nhan E; Rind DM; Pearson SD
    J Manag Care Spec Pharm; 2022 Jan; 28(1):108-114. PubMed ID: 34949111
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes Mellitus.
    Fazioli KT; Rind DM; Guzauskas GF; Hansen RN; Pearson SD
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1072-1076. PubMed ID: 32857658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value.
    McKenna A; Lin GA; Whittington MD; Nikitin D; Herron-Smith S; Campbell JD; Agboola F; Pearson SD
    J Manag Care Spec Pharm; 2023 Jul; 29(7):857-861. PubMed ID: 37404068
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis.
    Tice JA; Touchette DR; Lien PW; Agboola F; Nikitin D; Pearson SD
    J Manag Care Spec Pharm; 2022 Jan; 28(1):119-124. PubMed ID: 34949112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.